SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-14-001485
Filing Date
2014-01-30
Accepted
2014-01-30 13:32:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 sarepta.therapeutics.inc.txt SC 13G 11389
  Complete submission text file 0001086364-14-001485.txt   13410
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 14559927
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 EAST 52ND STREET NEW YORK NY 10022
Business Address 40 EAST 52ND STREET NEW YORK NY 10022 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies